Ascentage Pharma Group International ( ASPHF) - Key Metrics
ASPHF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.80 | -$2.16 | -$1.60 | -$1.64 |
| 2025Q4 | $0.90 | -$1.73 | -$2.11 | -$2.13 |
| 2025Q2 | $0.09 | -$0.24 | -$0.18 | -$1.32 |
| 2024Q4 | $0.53 | -$1.92 | $0.82 | $0.79 |
| 2024Q2 | $2.78 | $0.55 | -$1.20 | -$1.25 |
ASPHF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.54 |
| 2025Q4 | 0% | -8.47 |
| 2025Q2 | 0% | -6.02 |
| 2024Q4 | 0% | -2.56 |
| 2024Q2 | 0% | 8.89 |
ASPHF
Price: $3.75
52 week price:
Earnings Per Share: -0.59 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 billion